Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

The oncoprotein HBXIP up-regulates Skp2 via activating transcription factor E2F1 to promote proliferation of breast cancer cells.

Xu F, You X, Liu F, Shen X, Yao Y, Ye L, Zhang X.

Cancer Lett. 2013 Jun 1;333(1):124-32. doi: 10.1016/j.canlet.2013.01.029. Epub 2013 Jan 22.

PMID:
23352642
2.

The oncoprotein hepatitis B X-interacting protein promotes the migration of ovarian cancer cells through the upregulation of S-phase kinase-associated protein 2 by Sp1.

Xu F, Zhu X, Han T, You X, Liu F, Ye L, Zhang X, Wang X, Yao Y.

Int J Oncol. 2014 Jul;45(1):255-63. doi: 10.3892/ijo.2014.2411. Epub 2014 Apr 29.

PMID:
24788380
3.

The oncoprotein HBXIP upregulates PDGFB via activating transcription factor Sp1 to promote the proliferation of breast cancer cells.

Zhang Y, Zhao Y, Li L, Shen Y, Cai X, Zhang X, Ye L.

Biochem Biophys Res Commun. 2013 May 3;434(2):305-10. doi: 10.1016/j.bbrc.2013.02.123. Epub 2013 Mar 26.

PMID:
23537647
4.

The oncoprotein HBXIP activates transcriptional coregulatory protein LMO4 via Sp1 to promote proliferation of breast cancer cells.

Yue L, Li L, Liu F, Hu N, Zhang W, Bai X, Li Y, Zhang Y, Fu L, Zhang X, Ye L.

Carcinogenesis. 2013 Apr;34(4):927-35. doi: 10.1093/carcin/bgs399. Epub 2013 Jan 5.

5.

The oncoprotein HBXIP up-regulates SCG3 through modulating E2F1 and miR-509-3p in hepatoma cells.

Wang Y, Cui M, Cai X, Sun B, Liu F, Zhang X, Ye L.

Cancer Lett. 2014 Oct 1;352(2):169-78. doi: 10.1016/j.canlet.2014.05.007. Epub 2014 May 29.

PMID:
24882622
6.

The oncoprotein HBXIP upregulates Lin28B via activating TF II D to promote proliferation of breast cancer cells.

Liu Q, Bai X, Li H, Zhang Y, Zhao Y, Zhang X, Ye L.

Int J Cancer. 2013 Sep 15;133(6):1310-22. doi: 10.1002/ijc.28154. Epub 2013 Apr 5.

7.

The oncoprotein HBXIP enhances angiogenesis and growth of breast cancer through modulating FGF8 and VEGF.

Liu F, You X, Wang Y, Liu Q, Liu Y, Zhang S, Chen L, Zhang X, Ye L.

Carcinogenesis. 2014 May;35(5):1144-53. doi: 10.1093/carcin/bgu021. Epub 2014 Jan 24.

PMID:
24464787
8.

The oncoprotein HBXIP enhances migration of breast cancer cells through increasing filopodia formation involving MEKK2/ERK1/2/Capn4 signaling.

Li Y, Zhang Z, Zhou X, Li L, Liu Q, Wang Z, Bai X, Zhao Y, Shi H, Zhang X, Ye L.

Cancer Lett. 2014 Dec 28;355(2):288-96. doi: 10.1016/j.canlet.2014.09.047. Epub 2014 Oct 7.

PMID:
25304384
9.

HBV core promoter mutations promote cellular proliferation through E2F1-mediated upregulation of S-phase kinase-associated protein 2 transcription.

Huang Y, Tai AW, Tong S, Lok AS.

J Hepatol. 2013 Jun;58(6):1068-73. doi: 10.1016/j.jhep.2013.01.014. Epub 2013 Jan 21.

10.

The oncoprotein HBXIP up-regulates FGF4 through activating transcriptional factor Sp1 to promote the migration of breast cancer cells.

Shi H, Li Y, Feng G, Li L, Fang R, Wang Z, Qu J, Ding P, Zhang X, Ye L.

Biochem Biophys Res Commun. 2016 Feb 26;471(1):89-94. doi: 10.1016/j.bbrc.2016.01.174. Epub 2016 Jan 29.

PMID:
26828265
11.

The oncoprotein HBXIP up-regulates YAP through activation of transcription factor c-Myb to promote growth of liver cancer.

Wang Y, Fang R, Cui M, Zhang W, Bai X, Wang H, Liu B, Zhang X, Ye L.

Cancer Lett. 2017 Jan 28;385:234-242. doi: 10.1016/j.canlet.2016.10.018. Epub 2016 Oct 17.

PMID:
27765671
12.

The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells.

Liu S, Li L, Zhang Y, Zhang Y, Zhao Y, You X, Lin Z, Zhang X, Ye L.

J Biol Chem. 2012 Aug 31;287(36):30228-39. doi: 10.1074/jbc.M112.343947. Epub 2012 Jun 27.

13.

miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8.

Hu N, Zhang J, Cui W, Kong G, Zhang S, Yue L, Bai X, Zhang Z, Zhang W, Zhang X, Ye L.

J Biol Chem. 2011 Apr 15;286(15):13714-22. doi: 10.1074/jbc.M110.204131. Epub 2011 Feb 22.

14.

Oncoprotein HBXIP Modulates Abnormal Lipid Metabolism and Growth of Breast Cancer Cells by Activating the LXRs/SREBP-1c/FAS Signaling Cascade.

Zhao Y, Li H, Zhang Y, Li L, Fang R, Li Y, Liu Q, Zhang W, Qiu L, Liu F, Zhang X, Ye L.

Cancer Res. 2016 Aug 15;76(16):4696-707. doi: 10.1158/0008-5472.CAN-15-1734. Epub 2016 Mar 15.

15.

The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.

Shen Q, Uray IP, Li Y, Krisko TI, Strecker TE, Kim HT, Brown PH.

Oncogene. 2008 Jan 10;27(3):366-77. Epub 2007 Jul 16.

PMID:
17637753
16.

The oncoprotein HBXIP modulates the feedback loop of MDM2/p53 to enhance the growth of breast cancer.

Li H, Liu Q, Wang Z, Fang R, Shen Y, Cai X, Gao Y, Li Y, Zhang X, Ye L.

J Biol Chem. 2015 Sep 11;290(37):22649-61. doi: 10.1074/jbc.M115.658468. Epub 2015 Jul 30.

17.

E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.

Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y.

Oncogene. 2006 Jan 12;25(2):230-9.

PMID:
16158053
18.

HBXIP up-regulates ACSL1 through activating transcriptional factor Sp1 in breast cancer.

Wang Y, Cai X, Zhang S, Cui M, Liu F, Sun B, Zhang W, Zhang X, Ye L.

Biochem Biophys Res Commun. 2017 Mar 11;484(3):565-571. doi: 10.1016/j.bbrc.2017.01.126. Epub 2017 Jan 26.

PMID:
28132807
19.

E2F-1, Skp2 and cyclin E oncoproteins are upregulated and directly correlated in high-grade neuroendocrine lung tumors.

Salon C, Merdzhanova G, Brambilla C, Brambilla E, Gazzeri S, Eymin B.

Oncogene. 2007 Oct 18;26(48):6927-36. Epub 2007 Apr 30.

PMID:
17471231
20.

FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2.

Zuo T, Liu R, Zhang H, Chang X, Liu Y, Wang L, Zheng P, Liu Y.

J Clin Invest. 2007 Dec;117(12):3765-73.

Supplemental Content

Support Center